Skip to content

A study for evaluating the effect of low-protein brown rice on intestinal flora in patients with chronic kidney disease.

A study for evaluating the effect of low-protein brown rice on intestinal flora in patients with chronic kidney disease. - A study for evaluating the effect of low-protein brown rice on intestinal flora in patients with chronic kidney disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041832
Enrollment
30
Registered
2020-09-18
Start date
2020-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

After obtaining the consent, participants will stop using probiotics such as yogurt for three months. Participants then eat a protein-restricted diet for three months. Over the next three months, one

Sponsors

Division of Endocrinology, Metabolism and Nephrology Department of Internal Medicine Keio University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Outpatients with CKD stage 3 or lower. (eGFR less than 59 ml/min/1.73 m2, not including dialysis patients) . 2) Those who have not received protein restriction therapy. 3) Patients from whom written informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1) Patients in whom it is difficult to obtain sufficient samples for analysis. 2) Patients who have cognitive or physical impairments that make it difficult to follow a diet. 3) Patients with inflammatory bowel disease.

Design outcomes

Primary

MeasureTime frame
After obtaining the consent, participants will stop using probiotics such as yogurt for three months. After the initial assessment, participants consume a low-protein diet for 3 months and undergo a second assessment. After that, low-protein brown rice is consumed for 3 months and the final evaluation is performed. The intestinal flora is checked at each evaluation.

Secondary

MeasureTime frame
Assessment of inflammation-related parameters at each time point. (IL -6, leptin, indoxyl sulfate, p-cresyl sulfate, microRNA, exosome)

Countries

Japan

Contacts

Public ContactKeika Adachi

Department of internal medicine, Keio University, School of Medicine Division of Endocrinology, Metabolism and Nephrology

keika@a7.keio.jp+81-3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026